|
1
|
Ito Y, Miyauchi A, Kobayashi K and Miya A:
Prognosis and growth activity depend on patient age in clinical and
subclinical papillary thyroid carcinoma. Endocr J. 61:205–213.
2014. View Article : Google Scholar
|
|
2
|
Dalberg K, Eriksson E, Enberg U, Kjellman
M and Bäckdahl M: Gelatinase A, membrane type 1 matrix
metalloproteinase, and extracellular matrix metalloproteinase
inducer mRNA expression: Correlation with invasive growth of breast
cancer. World J Surg. 24:334–340. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Meert AP, Martin B, Paesmans M, Berghmans
T, Mascaux C, Verdebout JM, Delmotte P, Lafitte JJ and Sculier JP:
The role of HER-2/neu expression on the survival of patients with
lung cancer: A systematic review of the literature. Br J Cancer.
89:959–965. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Delellis RA, Lloyd RV, Heitx PU and Eng C:
Pathology and Genetics of Tumors of Endocrine Organs. World Health
Organization Classification of Tumours Lyon: pp. 73–76. 2004
|
|
5
|
Kramer MW, Merseburger AS, Hennenlotter J
and Kuczyk M: Tissue microarrays in clinical urology - technical
considerations. Scand J Urol Nephrol. 41:478–484. 2007. View Article : Google Scholar
|
|
6
|
Jawhar NM: Tissue microarray: A rapidly
evolving diagnostic and research tool. Ann Saudi Med. 29:123–127.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kallioniemi OP, Wagner U, Kononen J and
Sauter G: Tissue microarray technology for high-throughput
molecular profiling of cancer. Hum Mol Genet. 10:657–662. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hall M, Kazakova I and Yao YM: High
sensitivity immunoassays using particulate fluorescent labels. Anal
Biochem. 272:165–170. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hermanson GT: Bioconjugate Techniques. 2nd
edition. Academic Press; London, UK: pp. 297–416. 1996, View Article : Google Scholar
|
|
10
|
Sienel W, Polzer B, Elshawi K, et al:
Cellular localization of EMMPRIN predicts prognosis of patients
with operable lung adenocarcinoma independent from MMP-2 and MMP-9.
Mod Pathol. 21:1130–1138. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zheng HC, Takahashi H, Murai Y, et al:
Upregulated EMMPRIN/CD147 might contribute to growth and
angiogenesis of gastric carcinoma: A good marker for local invasion
and prognosis. Br J Cancer. 95:1371–1378. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Quemener C, Gabison EE, Naïmi B, et al:
Extracellular matrix metalloproteinase inducer up-regulates the
urokinase-type plasminogen activator system promoting tumor cell
invasion. Cancer Res. 67:9–15. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bougatef F, Quemener C, Kellouche S, et
al: EMMPRIN promotes angiogenesis through hypoxia-inducible
factor-2alpha-mediated regulation of soluble VEGF isoforms and
their receptor VEGFR-2. Blood. 114:5547–5556. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lu Q, Lv G, Kim A, Ha JM and Kim S:
Expression and clinical significance of extracellular matrix
metalloproteinase inducer, EMMPRIN/CD147, in human osteosarcoma.
Oncol Lett. 5:201–207. 2013.
|
|
15
|
Zheng H, Takahashi H, Murai Y, Cui Z,
Nomoto K, Miwa S, Tsuneyama K and Takano Y: Pathobiological
characteristics of intestinal and diffuse-type gastric carcinoma in
Japan: an immunostaining study on the tissue microarray. J Clin
Pathol. 60:273–277. 2007. View Article : Google Scholar
|
|
16
|
Chao WR, Lee MY, Lin WL, Chen CK, Lin JC,
Koo CL, Sheu GT and Han CP: HER2 amplification and overexpression
are significantly correlated in mucinous epithelial ovarian cancer.
Hum Pathol. 45:810–816. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Brennan PJ, Kumagai T, Berezov A, Murali R
and Greene MI: HER-2/neu: Mechanisms of
dimerization/oligomerization. Oncogene. 19:6093–6101. 2000.
View Article : Google Scholar
|
|
18
|
Lohrisch C and Piccart M: An overview of
HER2. Semin Oncol. 28(Suppl 18): 3–11. 2001. View Article : Google Scholar
|
|
19
|
Ho VW, Leung K, Hsu A, et al: A low
carbohydrate, high protein diet slows tumor growth and prevents
cancer initiation. Cancer Res. 71:4484–4493. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Debled M, Dalenc F, Mauriac L and Brain E:
Medical treatments of endocrine-sensitive Her-2 negative breast
cancers: A review. Bull Cancer. 98:655–670. 2011.(In French).
PubMed/NCBI
|
|
21
|
Menashi S, Serova M, Ma L, Vignot S,
Mourah S and Calvo F: Regulation of extracellular matrix
metalloproteinase inducer and matrix metalloproteinase expression
by amphiregulin in transformed human breast epithelial cells.
Cancer Res. 63:7575–7580. 2003.PubMed/NCBI
|
|
22
|
Auvinen P, Tammi R, Kosma VM, Sironen R,
Soini Y, Mannermaa A, Tumelius R, Uljas E and Tammi M: Increased
hyaluronan content and stromal cell CD44 associate with HER2
positivity and poor prognosis in human breast cancer. Int J Cancer.
132:531–539. 2013. View Article : Google Scholar
|
|
23
|
Papadopoulou E, Tripsianis G,
Anagnostopoulos K, Tentes I, Kakolyris S, Galazios G, Sivridis E,
Simopoulos K and Kortsaris A: The influence of serum HER-2 levels
and HER-2 codon 655 polymorphism on breast cancer outcome.
Neoplasma. 55:113–121. 2008.PubMed/NCBI
|
|
24
|
Yang Q, Liu Y, Huang Y, Huang D, Li Y, Wu
J and Duan M: Expression of COX-2, CD44v6 and CD147 and
relationship with invasion and lymph node metastasis in
hypopharyngeal squamous cell carcinoma. PLoS One. 8:e710482013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang T, Chen MH, Wu MY and Wu XY:
Correlation between expression of extracellular matrix
metalloproteinase inducer and matrix metalloproteinase-2 and
cervical lymph node metastasis of nasopharyngeal carcinoma. Ann
Otol Rhinol Laryngol. 122:210–215. 2013.PubMed/NCBI
|
|
26
|
Tan H, Ye K, Wang Z and Tang H: CD147
expression as a significant prognostic factor in differentiated
thyroid carcinoma. Transl Res. 152:143–149. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Suzuki S and Ishikawa K: Combined
inhibition of EMMPRIN and epidermal growth factor receptor prevents
the growth and migration of head and neck squamous cell carcinoma
cells. Int J Oncol. 44:912–917. 2014.PubMed/NCBI
|
|
28
|
Gialeli Ch, Theocharis AD, Kletsas D,
Tzanakakis GN and Karamanos NK: Expression of matrix macromolecules
and functional properties of EGF-responsive colon cancer cells are
inhibited by panitumumab. Invest New Drugs. 31:516–524. 2013.
View Article : Google Scholar
|
